{
    "clinical_study": {
        "@rank": "55414", 
        "arm_group": {
            "arm_group_label": "Study Group", 
            "description": "Applicable subjects less than 65 years of age identified in the Marketscan Commercial database during the period from July 2000 through April 2009, and October 2010 to May 2011 and subjects 65 years of age and older identified in MarketScan Medicare Supplemental database during the period from July 2006 through April 2009, and October 2010 to May 2011."
        }, 
        "brief_summary": {
            "textblock": "This is a database study to quantify the burden of multiple mild outcomes (i.e., those that\n      result in visits to a physician's office) attributable to influenza in the United States,\n      stratified by age group, geographic region and influenza subtype for selected influenza\n      seasons."
        }, 
        "brief_title": "Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Influenza", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "detailed_description": {
            "textblock": "This is a retrospective database study to quantify the burden of multiple mild pre-defined\n      influenza-attributable outcomes of interest, which resulted in physician office visits for\n      persons who were less than 65 years of age, in the United States in the relevant Marketscan\n      Commercial database in the period from July 2000 through April 2009, and October 2010 to May\n      2011. The corresponding physician office visits for persons 65 years of age and older, with\n      a mild influenza-attributable outcome of interest, in the United States that were recorded\n      in the relevant MarketScan Medicare Supplemental database in the period from July 2006\n      through April 2009, and October 2010 to May 2011 were also investigated. The period from\n      April 2009 through September 2010 is excluded to avoid the H1N1 pandemic wave."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        \u2022  Recorded in a Marketscan database with any of the specified diagnostic codes.\n\n        Exclusion Criteria:\n\n        \u2022  Missing data in any of the following fields: age, diagnosis, region or visit date."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All records related to physician office visits of subjects less than 65 years of age and\n        65 years of age and older in the United States with an outcome of interest in the relevant\n        Marketscan database."
            }
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019732", 
            "org_study_id": "117233"
        }, 
        "intervention": {
            "arm_group_label": "Study Group", 
            "description": "Data collection from existing electronic healthcare databases (Marketscan Commercial database, MarketScan Medicare Supplemental database).", 
            "intervention_name": "Data collection", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Mild outcomes", 
            "Database", 
            "Influenza-attributable", 
            "Retrospective", 
            "Influenza", 
            "United States of America (USA)"
        ], 
        "lastchanged_date": "January 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20814"
                }, 
                "name": "GSK Investigational Site"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Burden of Mild Outcomes Due to Influenza in the United States, July 2000 Through April 2009 and October 2010 to May 2011", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: No Health Authority"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "-\tAll the events contained within \"potentially influenza-attributable\" office visits.  -\tWeekly proportion of circulating influenza A and B strains determined for each season.", 
            "measure": "Weekly occurrences of potentially influenza-attributable physician's office visits by age, region and season.", 
            "safety_issue": "No", 
            "time_frame": "Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database)."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019732"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Assessment of Influenza vaccine content and effectiveness by season.", 
                "safety_issue": "No", 
                "time_frame": "Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database)."
            }, 
            {
                "measure": "Assessment of Influenza vaccine coverage by season and region.", 
                "safety_issue": "No", 
                "time_frame": "Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database)."
            }, 
            {
                "measure": "Assessment of Influenza B vaccine mismatch (by region and season).", 
                "safety_issue": "No", 
                "time_frame": "Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database)."
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}